Search Results - "Bal, Hamit"
-
1
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy
Published in Scientific reports (27-05-2024)“…Neoadjuvant chemotherapy (NACT) is the standard treatment for locally advanced, high-risk breast cancer. Pathological complete response (pCR) improves…”
Get full text
Journal Article -
2
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer
Published in Medicina (Kaunas, Lithuania) (01-06-2024)“…Patients with human epidermal growth factor receptor 2 (HER2) -positive, hormone receptor-positive (HR-positive) metastatic breast cancer (MBC) usually undergo…”
Get full text
Journal Article -
3
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER Status
Published in Chemotherapy (Basel) (2024)“…Neoadjuvant chemotherapy (NAC) is extensively employed in breast cancer (BC), primarily for aggressive subtypes like triple-negative and human epidermal growth…”
Get more information
Journal Article -
4
Ticagrelor-associated thrombotic thrombocytopenic purpura
Published in Anatolian journal of cardiology (01-01-2017)“…A 31-year-old male patient with no medical history or medication use presented at emergency department with chest pain that had been ongoing for 2 hours…”
Get full text
Journal Article